Advertisement

A population-based comparison of European and North American sinonasal cancer survival

  • Aykut A. Unsal
    Affiliations
    Department of Otolaryngology & Facial Plastic Surgery, Rowan University School of Osteopathic Medicine, Stratford, New Jersey, USA
    Search for articles by this author
  • Suat Kılıç
    Affiliations
    Department of Otolaryngology – Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA
    Search for articles by this author
  • Pariket M. Dubal
    Affiliations
    Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, Pennsylvania, USA
    Search for articles by this author
  • Soly Baredes
    Affiliations
    Department of Otolaryngology – Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA

    Center for Skull Base and Pituitary Surgery, Neurological Institute of New Jersey, Rutgers New Jersey Medical School, Newark, New Jersey, USA
    Search for articles by this author
  • Jean Anderson Eloy
    Correspondence
    Corresponding author at: Neurological Institute of New Jersey, Rutgers New Jersey Medical School, 90 Bergen St., Suite 8100, Newark, NJ 07103, United States. Fax: +(1) 973 972 3767.
    Affiliations
    Department of Otolaryngology – Head and Neck Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA

    Center for Skull Base and Pituitary Surgery, Neurological Institute of New Jersey, Rutgers New Jersey Medical School, Newark, New Jersey, USA

    Department of Neurological Surgery, Rutgers New Jersey Medical School, Newark, New Jersey, USA

    Department of Ophthalmology and Visual Science, Rutgers New Jersey Medical School, Newark, New Jersey, USA
    Search for articles by this author
  • EUROCARE-5 Working Group
    Author Footnotes
    1 See Appendix A.
  • Author Footnotes
    1 See Appendix A.
Published:October 19, 2017DOI:https://doi.org/10.1016/j.anl.2017.09.009

      Abstract

      Objective

      Sinonasal cancers (SNC) are rare, thus limiting previous prognostic studies on a multinational level. The aim of this study is to utilize two population-based datasets to compare prognoses for SNC between the United States (US) and Europe.

      Methods

      The European Cancer Registry (EUROCARE) database and the United States National Cancer Institute’s Surveillance, Epidemiology, and End Results (SEER) database were searched to identify survival of patients diagnosed with SNC between 1990 and 2007. Relative survival (RS) data were stratified by age group, gender, geographic location, and diagnostic time period.

      Results

      12,541 SNC cases were identified in EUROCARE, while SEER identified 4,312. Males comprised the majority in Europe (62.3%) and the US (58.3%). Most patients were over 55 years in Europe (77.0%) and the US (69.5%). Age over 75 was a statistically significant poor prognostic indicator for 5-year RS in the US (48.2%; 95% CI = [43.9, 52.4]) and Europe (38.5%; [34.7, 42.7]). Female gender imparted a favorable 5-year RS in all regions except in Central Europe. By region, the US had the highest 5-year RS (58.8%; [56.4, 61.1]) and Eastern Europe had the lowest 5-year RS (37.1%; [34.0, 40.6]). The aggregate European 5-year RS was 48.1% [46.4, 49.8].

      Conclusion

      SNC in Europe and the US most commonly affects males and individuals over the age of 55 years. Male gender and age over 75 are poor prognostic factors at 5 years. Five-year RS in the US is higher than the 5-year European aggregate RS.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Auris Nasus Larynx
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kilic S.
        • Shukla P.A.
        • Marchiano E.J.
        • Patel R.H.
        • Baredes S.
        • Liu J.K.
        • et al.
        Malignant primary neoplasms of the nasal cavity and paranasal sinus.
        Curr Otorhinolaryngol Rep. 2016; : 1-10
        • Unsal A.A.
        • Dubal P.M.
        • Patel T.D.
        • Vazquez A.
        • Baredes S.
        • Liu J.K.
        • et al.
        Squamous cell carcinoma of the nasal cavity: a population-based analysis.
        Laryngoscope. 2016; 126: 560-565
        • Turner J.H.
        • Reh D.D.
        Incidence and survival in patients with sinonasal cancer: a historical analysis of population-based data.
        Head Neck. 2012; 34: 877-885
        • Slack R.
        • Young C.
        • Rushton L.
        British occupational cancer burden study G. Occupational cancer in Britain. Nasopharynx and sinonasal cancers.
        Br J Cancer. 2012; 107: S49-S55
        • Ansa B.
        • Goodman M.
        • Ward K.
        • Kono S.A.
        • Owonikoko T.K.
        • Higgins K.
        • et al.
        Paranasal sinus squamous cell carcinoma incidence and survival based on Surveillance, Epidemiology, and End Results data, 1973 to 2009.
        Cancer. 2013; 119: 2602-2610
        • De Angelis R.
        • Sant M.
        • Coleman M.P.
        • Francisci S.
        • Baili P.
        • Pierannunzio D.
        • et al.
        Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 — a population-based study.
        Lancet Oncol. 2014; 15: 23-34
      1. REGISTRY EC, AND BSOS, PATIENTS COC. 2016. Available from: http://www.eurocare.it/.

      2. REGISTRY EC, AND BSOS, PATIENTS COC. Cancer entities included in EUROCARE-5 survival analyses. Site definitions are according to the third revision of the International Classification of Diseases for Oncology (ICD-O-3) [cited 2016 10/07]. Available from: https://w3.iss.it/site/EU5Results/docs/Cancer_entities_included_in_EUROCARE_5.pdf.

        • Gavin A.T.
        • Francisci S.
        • Foschi R.
        • Donnelly D.W.
        • Lemmens V.
        • Brenner H.
        • et al.
        Oesophageal cancer survival in Europe: a EUROCARE-4 study.
        Cancer Epidemiol. 2012; 36: 505-512
        • Sant M.
        • Aareleid T.
        • Berrino F.
        • Bielska Lasota M.
        • Carli P.M.
        • Faivre J.
        • et al.
        EUROCARE-3: survival of cancer patients diagnosed 1990–94 — results and commentary.
        Ann Oncol. 2003; 14: v61-v118
        • Greenland S.
        • Senn S.J.
        • Rothman K.J.
        • Carlin J.B.
        • Poole C.
        • Goodman S.N.
        • et al.
        Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations.
        Eur J Epidemiol. 2016; 31: 337-350
        • Youlden D.R.
        • Cramb S.M.
        • Peters S.
        • Porceddu S.V.
        • Moller H.
        • Fritschi L.
        • et al.
        International comparisons of the incidence and mortality of sinonasal cancer.
        Cancer Epidemiol. 2013; 37: 770-779
      3. World Health Organization. Life expectancy: Global Health Observatory Data http://www.who.int/gho/mortality_burden_disease/life_tables/situation_trends/en/: World Health Organization; 2015. Available from: http://www.who.int/gho/mortality_burden_disease/life_tables/situation_trends/en/.

        • Mensi C.
        • Consonni D.
        • Sieno C.
        • De Matteis S.
        • Riboldi L.
        • Bertazzi P.A.
        Sinonasal cancer and occupational exposure in a population-based registry.
        Int J Otolaryngol. 2013; 2013: 672621
        • Ericksen M.M.J.
        • Schluger N.
        • Gomeshtapeh F.I.
        • Drope J.
        The Tobacco Atlas: American Cancer Society.
        World Lung Foundation, 2015
        • Bader P.
        • Boisclair D.
        • Ferrence R.
        Effects of tobacco taxation and pricing on smoking behavior in high risk populations: a knowledge synthesis.
        Int J Environ Res Public Health. 2011; 8: 4118-4139
        • Kuijpens J.H.
        • Louwman M.W.
        • Peters R.
        • Janssens G.O.
        • Burdorf A.L.
        • Coebergh J.W.
        Trends in sinonasal cancer in The Netherlands: more squamous cell cancer, less adenocarcinoma. A population-based study 1973–2009.
        Eur J Cancer. 2012; 48: 2369-2374
        • Jones P.A.
        • Smith L.C.
        Personal exposures to wood dust of woodworkers in the furniture industry in the High Wycombe area: a statistical comparison of 1983 and 1976/77 survey results.
        Ann Occup Hyg. 1986; 30: 171-184
        • Schlunssen V.
        • Jacobsen G.
        • Erlandsen M.
        • Mikkelsen A.B.
        • Schaumburg I.
        • Sigsgaard T.
        Determinants of wood dust exposure in the Danish furniture industry–results from two cross-sectional studies 6 years apart.
        Ann Occup Hyg. 2008; 52: 227-238
        • Coble J.B.
        • Lees P.S.
        • Matanoski G.
        Time trends in exposure measurements from OSHA compliance inspections of the pulp and paper industry.
        Appl Occup Environ Hyg. 2001; 16: 263-270
        • Galea K.S.
        • Van Tongeren M.
        • Sleeuwenhoek A.J.
        • While D.
        • Graham M.
        • Bolton A.
        • et al.
        Trends in wood dust inhalation exposure in the UK, 1985–2005.
        Ann Occup Hyg. 2009; 53: 657-667
        • Van Dijk B.A.
        • Gatta G.
        • Capocaccia R.
        • Pierannunzio D.
        • Strojan P.
        • Licitra L.
        • et al.
        Rare cancers of the head and neck area in Europe.
        Eur J Cancer. 2012; 48: 783-796
        • D'Aguillo C.M.
        • Kanumuri V.V.
        • Khan M.N.
        • Sanghvi S.
        • Patel N.R.
        • Baredes S.
        • et al.
        Demographics and survival trends of sinonasal adenocarcinoma from 1973 to 2009.
        Int Forum Allergy Rhinol. 2014; 4: 771-776
        • Micheli A.
        • Ciampichini R.
        • Oberaigner W.
        • Ciccolallo L.
        • de Vries E.
        • Izarzugaza I.
        • et al.
        The advantage of women in cancer survival: an analysis of EUROCARE-4 data.
        Eur J Cancer. 2009; 45: 1017-1027
        • Gatta G.
        • Botta L.
        • Sanchez M.J.
        • Anderson L.A.
        • Pierannunzio D.
        • Licitra L.
        • et al.
        Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study.
        Eur J Cancer. 2015; 51: 2130-2143
        • Rosenblatt E.
        • Izewska J.
        • Anacak Y.
        • Pynda Y.
        • Scalliet P.
        • Boniol M.
        • et al.
        Radiotherapy capacity in European countries: an analysis of the Directory of Radiotherapy Centres (DIRAC) database.
        Lancet Oncol. 2013; 14: e79-86
        • Koch W.M.
        • Patel H.
        • Brennan J.
        • Boyle J.O.
        • Sidransky D.
        Squamous cell carcinoma of the head and neck in the elderly.
        Arch Otolaryngol Head Neck Surg. 1995; 121: 262-265
        • Syrigos K.N.
        • Karachalios D.
        • Karapanagiotou E.M.
        • Nutting C.M.
        • Manolopoulos L.
        • Harrington K.J.
        Head and neck cancer in the elderly: an overview on the treatment modalities.
        Cancer Treat Rev. 2009; 35: 237-245
        • Reid B.C.
        • Alberg A.J.
        • Klassen A.C.
        • Samet J.M.
        • Rozier R.G.
        • Garcia I.
        • et al.
        Comorbidity and survival of elderly head and neck carcinoma patients.
        Cancer. 2001; 92: 2109-2116